May 4, 2025 - 05:35

Researchers at Dartmouth College are exploring the potential of artificial intelligence to provide effective psychotherapy, setting their work apart from the myriad of unverified mental health applications currently available. The team is focused on developing AI systems that can deliver reliable and evidence-based therapeutic interventions, addressing a growing need for accessible mental health care solutions.
As mental health issues continue to rise, the demand for effective treatment options has never been greater. Traditional therapy can be costly and difficult to access for many individuals. By harnessing the power of AI, the researchers aim to create tools that can offer support and guidance to those in need, while ensuring that the methods used are grounded in scientific research.
The initiative seeks not only to enhance the quality of mental health care but also to establish a framework for validating AI-driven therapies. This could pave the way for a new era in mental health treatment, where technology plays a crucial role in supporting individuals on their journey to well-being.
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...
July 20, 2026 - 11:31
Seven peptides are under review by an FDA panel this week. Here’s everything we knowA federal advisory committee is set to meet this week to evaluate seven peptide products, a move that could reshape how these compounds are made and prescribed in the United States. The panel,...